Rank | Drug | Current Manufacturer | Total Sales ($000) | % change 2008 |
1 | Lipitor | Pfizer Inc | 5,363,193 | -8.8% |
2 | Nexium | AstraZeneca Pharmaceuticals | 5,014,827 | 4.6% |
3 | Plavix | Bristol-Myers Squibb Company | 4,223,124 | 11.2% |
4 | Advair Diskus | GlaxoSmithKline | 3,653,410 | 2.3% |
5 ( 1) | Seroquel | AstraZeneca Pharmaceuticals | 3,117,591 | 7.2% |
6 ( 6) | Abilify | Bristol-Myers Squibb Company | 3,083,351 | 30.0% |
7 | Singulair | Merck & Co., Inc. | 3,027,378 | 4.5% |
8 ( 1) | OxyContin | Purdue Pharma LP | 3,020,239 | 20.7% |
9 ( 1) | Actos | Takeda Pharmaceuticals North America, Inc | 2,531,621 | 3.4% |
10 ( 5) | Prevacid | Takeda Pharmaceuticals North America, Inc | 2,508,555 | -23.9% |
11 ( 3) | Cymbalta | Eli Lilly and Company | 2,404,353 | 10.8% |
12 ( 4) | Effexor XR | Wyeth | 2,385,507 | -10.2% |
13 ( 2) | Lexapro | Forest Pharmaceuticals, Inc | 2,334,422 | -3.2% |
14 ( 3) | Crestor | AstraZeneca Pharmaceuticals | 2,308,138 | 37.7% |
15 | Zyprexa | Eli Lilly and Company | 1,855,436 | 6.1% |
16 | Valtrex | GlaxoSmithKline | 1,754,727 | 4.2% |
17 ( 10) | Flomax | Boehringer Ingelheim Pharmaceuticals, Inc | 1,556,273 | 25.8% |
18 ( 3) | Lantus | Sanofi-Aventis | 1,512,403 | 2.5% |
19 ( 5) | Lyrica | Pfizer Inc | 1,445,445 | 4.0% |
20 | Celebrex | Pfizer Inc | 1,437,539 | -5.8% |
21 ( 1) | Levaquin | Janssen Pharmaceuticals, Inc | 1,373,131 | -6.0% |
22 ( 9) | Aricept | Eisai Corporation | 1,347,293 | 17.2% |
23 ( 9) | Spiriva | Boehringer Ingelheim Pharmaceuticals, Inc | 1,338,252 | 17.1% |
24 ( 1) | Diovan | Novartis Corporation | 1,328,515 | 3.5% |
25 ( 4) | Diovan HCT | Novartis Corporation | 1,244,245 | 2.6% |
26 | Tricor | Abbott Laboratories | 1,224,894 | -2.0% |
27 ( 6) | Concerta | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 1,180,887 | 7.0% |
28 ( 13) | Januvia | Merck & Co., Inc. | 1,145,933 | 25.4% |
29 ( 11) | Vytorin | Merck & Co., Inc. | 1,133,438 | -26.7% |
30 ( 7) | Adderall XR | Shire US Inc | 1,130,274 | -21.9% |
31 ( 9) | Lovenox | Sanofi-Aventis | 1,075,620 | 17.7% |
32 ( 7) | Atripla | Gilead Sciences, Inc. | 1,064,056 | 16.2% |
33 ( 3) | Zetia | Schering-Plough | 1,025,238 | -13.4% |
34 | Aciphex | Eisai Corporation | 996,052 | -5.3% |
35 ( 8) | Ambien CR | Sanofi-Aventis | 983,296 | 13.6% |
36 ( 2) | Viagra | Pfizer Inc | 974,727 | 5.9% |
37 ( 24) | Topamax | Janssen Pharmaceuticals, Inc | 939,312 | -55.9% |
38 ( 2) | Lidoderm | Endo Pharmaceuticals | 937,263 | -3.4% |
39 ( 33) | ProAir HFA | Teva Pharmaceuticals | 935,532 | 77.3% |
40 ( ) | NovoLog | Novo Nordisk Inc. | 905,235 | 26.6% |
41 ( 29) | Suboxone | Reckitt Benckiser Pharmaceuticals Inc. | 894,208 | 68.1% |
42 | Nasonex | Schering-Plough | 893,579 | -1.2% |
43 ( 1) | Provigil | Cephalon, Inc. | 883,339 | 4.4% |
44 ( 1) | Geodon Oral | Pfizer Inc | 873,952 | 9.6% |
45 ( 1) | Truvada | Gilead Sciences, Inc. | 862,711 | 11.2% |
46 ( 1) | Lunesta | Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) | 813,087 | 5.5% |
47 ( 4) | Humalog | Eli Lilly and Company | 757,108 | 7.7% |
48 ( 8) | Niaspan | Abbott Laboratories | 716,589 | 12.2% |
49 ( 3) | Detrol LA | Pfizer Inc | 711,749 | 2.1% |
50 ( 11) | Yaz | Bayer Healthcare Pharmaceuticals | 701,540 | 19.8% |
51 ( 3) | Cozaar | Merck & Co., Inc. | 697,815 | 1.1% |
52 ( 11) | Namenda | Forest Pharmaceuticals, Inc | 670,226 | 15.1% |
53 ( 43) | Vyvanse | Shire US Inc | 660,109 | 76.0% |
54 ( 68) | Tamiflu | Roche Pharmaceuticals | 651,444 | 136.8% |
55 ( 11) | Cialis | Eli Lilly and Company | 650,494 | 17.2% |
56 ( 8) | Arimidex | AstraZeneca Pharmaceuticals | 640,326 | 12.6% |
57 ( 9) | Enbrel | Amgen Inc. | 638,695 | -16.4% |
58 ( 9) | Flovent HFA | GlaxoSmithKline | 621,041 | 12.3% |
59 ( 52) | Lantus SoloStar | Sanofi-Aventis | 610,161 | 93.1% |
60 ( 5) | Combivent | Boehringer Ingelheim Pharmaceuticals, Inc | 608,121 | 8.9% |
61 ( 6) | Pulmicort Respules | AstraZeneca Pharmaceuticals | 607,397 | -6.7% |
62 ( 2) | Byetta | Amylin Pharmaceuticals, Inc. | 554,861 | -6.7% |
63 ( 11) | Benicar HCT | Daiichi Sankyo | 553,640 | 7.5% |
64 ( 24) | AndroGel | Solvay Pharmaceuticals, Inc. | 546,994 | 24.0% |
65 ( 3) | Prograf | Astellas Pharma US | 541,151 | -7.4% |
66 ( 5) | Hyzaar | Merck & Co., Inc. | 539,827 | 2.2% |
67 ( 19) | Benicar | Daiichi Sankyo | 526,569 | 15.6% |
68 ( 1) | Premarin tabs | Wyeth | 520,151 | -5.2% |
69 ( 18) | Gleevec | Novartis Corporation | 519,508 | 15.3% |
70 ( 3) | Reyataz | Bristol-Myers Squibb Company | 519,018 | -0.1% |
71 ( 6) | Boniva | Roche Pharmaceuticals | 511,277 | -0.2% |
72 ( 6) | Strattera | Eli Lilly and Company | 511,187 | -0.1% |
73 ( 54) | Lamictal | GlaxoSmithKline | 498,599 | -67.6% |
74 ( 1) | Synthroid | Abbott Laboratories | 495,523 | -3.8% |
75 ( 7) | Asacol | Procter & Gamble | 491,311 | 5.9% |
76 ( 63) | Symbicort | AstraZeneca Pharmaceuticals | 487,690 | 105.0% |
77 ( 8) | Humira Pen | Abbott Laboratories | 487,601 | 27.8% |
78 ( 32) | Solodyn | Medicis Pharmaceutical Corporation | 479,365 | 51.7% |
79 ( 31) | Enbrel Sureclick | Amgen Inc. | 479,132 | 10.5% |
80 ( 22) | Chantix | Pfizer Inc | 472,207 | -22.0% |
81 ( 1) | Skelaxin | Elan Corporation | 472,083 | -5.8% |
82 ( 32) | CellCept | Roche Pharmaceuticals | 468,229 | -34.2% |
83 ( 2) | Evista | Eli Lilly and Company | 466,955 | -6.6% |
84 ( 16) | Protonix | Wyeth | 461,079 | -16.6% |
85 ( 1) | Xalatan | Pfizer Inc | 457,121 | 0.2% |
86 ( 37) | Actonel | Procter & Gamble | 435,977 | -39.0% |
87 ( 12) | Copaxone | Sanofi-Aventis | 428,384 | 15.6% |
88 ( 13) | Femara | Novartis Corporation | 427,132 | 18.3% |
89 ( 19) | Mirapex | Boehringer Ingelheim Pharmaceuticals, Inc | 417,934 | 24.6% |
90 ( 10) | Avodart | GlaxoSmithKline | 416,285 | 14.1% |
91 ( 15) | Avandia | GlaxoSmithKline | 407,906 | -20.6% |
92 ( 7) | Humira | Abbott Laboratories | 402,654 | -11.7% |
93 ( 13) | NovoLog Mix 70/30 | Novo Nordisk Inc. | 400,683 | 15.4% |
94 | Avapro | Bristol-Myers Squibb Company | 398,768 | -1.7% |
95 ( 12) | Restasis | Allergan, Inc | 398,143 | 17.4% |
96 ( 31) | Levemir | Novo Nordisk Inc. | 394,246 | 53.9% |
97 ( 7) | Avelox | Bayer Healthcare Pharmaceuticals | 388,933 | -9.3% |
98 ( 17) | Vesicare | Astellas Pharma US | 379,283 | 26.8% |
99 ( 41) | Janumet | Merck & Co., Inc. | 378,837 | 59.6% |
100 ( 4) | Sensipar | Amgen Inc. | 369,011 | 5.9% |
101 ( 4) | Aldara | Graceway Pharmaceuticals, LLC | 366,825 | 5.5% |
102 ( 4) | Xopenex | Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) | 356,898 | -4.1% |
103 ( ) | Seroquel XR | AstraZeneca Pharmaceuticals | 356,402 | 151.8% |
104 ( 9) | Focalin XR | Novartis Corporation | 352,024 | 13.6% |
105 ( 12) | RenaGel | Genzyme Corporation | 351,383 | -14.0% |
106 ( 4) | Avalide | Bristol-Myers Squibb Company | 350,462 | -1.5% |
107 ( 70) | Keppra | UCB Inc. | 339,978 | -63.9% |
108 ( 6) | Actoplus Met | Takeda Pharmaceuticals North America, Inc | 338,930 | 12.5% |
109 ( ) | Caduet | Pfizer Inc | 331,382 | -15.0% |
110 ( ) | Lotrel | Novartis Corporation | 323,873 | -12.0% |
111 ( 13) | NuvaRing | Merck & Co., Inc. | 318,518 | 19.2% |
112 | Norvir | Abbott Laboratories | 311,949 | 0.2% |
113 ( 16) | Kaletra | Abbott Laboratories | 309,015 | -17.2% |
114 ( ) | Ventolin HFA | GlaxoSmithKline | 297,759 | 285.3% |
115 ( 62) | Isentress | Merck & Co., Inc. | 286,333 | 63.2% |
116 ( 16) | Invega | Janssen Pharmaceuticals, Inc | 280,698 | 14.1% |
117 ( ) | Prevacid SoluTab | Takeda Pharmaceuticals North America, Inc | 276,710 | NA |
118 ( 11) | Risperdal Consta | Janssen Pharmaceuticals, Inc | 274,523 | 9.4% |
119 ( 66) | Depakote ER | Abbott Laboratories | 272,177 | -60.7% |
120 ( 3) | Avonex | Biogen Idec | 271,515 | -0.7% |
121 ( 70) | Doryx | Pfizer Inc | 268,774 | 69.6% |
122 ( 36) | Loestrin 24 Fe | Warner Chilcott | 267,190 | 33.4% |
123 ( 7) | Forteo | Eli Lilly and Company | 266,923 | -8.5% |
124 ( ) | Pristiq | Wyeth | 266,654 | 397.5% |
125 ( 1) | Epzicom | GlaxoSmithKline | 260,282 | -1.9% |
126 ( 6) | Tarceva | Genentech, Inc | 257,591 | -7.0% |
127 ( 16) | Proventil HFA | Schering-Plough | 257,440 | 13.0% |
128 ( ) | Aggrenox | Boehringer Ingelheim Pharmaceuticals, Inc | 256,362 | 4.2% |
129 ( 9) | Lumigan | Allergan, Inc | 255,177 | 7.0% |
130 ( 5) | Coreg CR | GlaxoSmithKline | 253,377 | -4.7% |
131 ( 14) | Allegra-D 12 Hour | Sanofi-Aventis | 252,670 | -12.3% |
132 ( 22) | Welchol | Daiichi Sankyo | 252,474 | 20.6% |
133 ( 2) | Levitra | Bayer Healthcare Pharmaceuticals | 252,148 | 5.1% |
134 | Kadian | Actavis | 250,497 | 2.5% |
135 ( 32) | Ortho Tri-Cyclen Lo | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 250,337 | -28.6% |
136 ( 5) | Xeloda | Roche Pharmaceuticals | 246,919 | 4.5% |
137 ( ) | Toprol XL | AstraZeneca Pharmaceuticals | 242,561 | 71.0% |
138 ( 10) | Maxalt | Merck & Co., Inc. | 240,341 | 9.9% |
139 ( 20) | Nasacort AQ | Sanofi-Aventis | 239,549 | -16.1% |
140 ( 10) | Zyvox | Pfizer Inc | 238,542 | -4.5% |
141 ( 54) | Opana ER | Endo Pharmaceuticals | 235,624 | 51.4% |
142 ( 24) | Procrit | Centocor Ortho Biotech, Inc | 233,804 | -18.8% |
143 ( 12) | Tussionex | Sanofi-Aventis | 232,821 | -5.6% |
144 ( 87) | Wellbutrin XL | Valeant Pharmaceuticals International | 231,227 | -62.3% |
145 ( ) | Exforge | Novartis Corporation | 228,459 | 53.4% |
146 ( 10) | Differin | Galderma Laboratories | 227,198 | -5.2% |
147 ( ) | Humalog Mix 75/25 Pen | Eli Lilly and Company | 226,135 | -0.4% |
148 ( 27) | Combivir | GlaxoSmithKline | 225,097 | -18.4% |
149 ( 3) | Vigamox | Alcon Laboratories, Inc. | 224,627 | 1.8% |
150 ( 6) | Viread | Gilead Sciences, Inc. | 223,915 | 7.9% |
151 ( ) | Trilipix | Abbott Laboratories | 221,001 | NA |
152 ( 3) | Ciprodex Otic | Alcon Laboratories, Inc. | 218,781 | 5.3% |
153 ( 104) | Actonel 150 | Procter & Gamble | 210,266 | 339.3% |
154 ( ) | Maxalt MLT | Merck & Co., Inc. | 210,049 | 9.2% |
155 ( 27) | Duragesic | | 209,926 | -16.6% |
156 ( 14) | Asmanex | Schering-Plough | 206,633 | 11.5% |
157 ( 6) | Relpax | Pfizer Inc | 204,273 | -4.2% |
158 ( ) | Entocort EC | AstraZeneca Pharmaceuticals | 200,489 | 55.0% |
159 ( 14) | BenzaClin | Sanofi-Aventis | 198,107 | -12.3% |
160 ( 22) | Micardis | Boehringer Ingelheim Pharmaceuticals, Inc | 197,550 | 19.0% |
161 ( 15) | Enablex | Warner Chilcott | 197,312 | 11.9% |
162 ( 11) | Micardis HCT | Abbott Laboratories | 197,278 | 9.4% |
163 ( ) | Prezista | Centocor Ortho Biotech, Inc | 191,366 | 48.1% |
164 ( 2) | Revlimid | Celgene Corporation | 190,965 | -1.8% |
165 ( ) | Travatan Z | Alcon Laboratories, Inc. | 190,516 | 56.9% |
166 ( 15) | Amitiza | Takeda Pharmaceuticals North America, Inc | 190,101 | 12.1% |
167 ( 7) | Alphagan P | Allergan, Inc | 188,803 | -3.6% |
168 ( 1) | Pegasys | Roche Pharmaceuticals | 188,536 | 0.3% |
169 ( 17) | Patanol | Alcon Laboratories, Inc. | 187,599 | -11.3% |
170 ( ) | Xyzal | UCB Inc. | 187,542 | 30.0% |
171 ( 2) | Fentora | Cephalon, Inc. | 185,528 | 0.2% |
172 ( 15) | Catapres-TTS | Boehringer Ingelheim Pharmaceuticals, Inc | 184,799 | -9.7% |
173 ( 31) | Clarinex | Schering-Plough | 181,215 | -22.4% |
174 ( 11) | Avandamet | GlaxoSmithKline | 178,188 | -7.6% |
175 ( 38) | Astelin | Meda Pharmaceuticals | 177,778 | -25.7% |
176 ( 8) | Ultram ER | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 174,664 | -5.7% |
177 ( 6) | Zovirax topical | GlaxoSmithKline | 174,423 | 5.7% |
178 ( 10) | Valcyte | Roche Pharmaceuticals | 174,413 | 8.6% |
179 ( ) | Uroxatral | Sanofi-Aventis | 174,034 | 21.6% |
180 ( ) | Lialda | Shire US Inc | 173,802 | 54.6% |
181 ( 9) | Temodar | Schering-Plough | 172,475 | -5.8% |
182 ( ) | Pentasa | Sanofi-Aventis | 171,083 | 17.0% |
183 ( 11) | Allegra-D 24 Hour | Sanofi-Aventis | 167,692 | 7.2% |
184 ( 1) | Propecia | Merck & Co., Inc. | 166,878 | 2.3% |
185 ( ) | Vivelle-DOT | Novartis Corporation | 165,828 | 10.9% |
186 ( ) | Zegerid | Santarus, Inc. | 164,756 | 17.7% |
187 ( ) | Premarin Vaginal | Wyeth | 164,568 | 10.0% |
188 ( ) | Exelon Patch | Novartis Corporation | 162,259 | 74.4% |
189 ( 9) | Prempro | Wyeth | 161,662 | 5.9% |
190 ( ) | Prandin | Novo Nordisk Inc. | 161,651 | 10.4% |
191 ( 156) | Imitrex Oral | GlaxoSmithKline | 161,167 | -83.4% |
192 | Veramyst | GlaxoSmithKline | 160,387 | 1.3% |
193 ( 7) | Taclonex | Warner Chilcott | 159,082 | -1.6% |
194 ( 6) | Xopenex HFA | Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) | 157,588 | 3.7% |
195 ( ) | Duac Care System | Stiefel Laboratories, Inc. | 155,643 | 9.3% |
196 ( 7) | Klor-Con | Upsher-Smith Laboratories Inc. | 153,842 | -3.6% |
197 ( ) | Epipen | | 153,802 | 18.4% |
198 ( 5) | Avinza | King Pharmaceuticals, Inc. | 153,393 | -2.4% |
199 ( 9) | Atacand | AstraZeneca Pharmaceuticals | 152,603 | -4.4% |
200 ( ) | Elmiron | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 150,961 | 10.0% |
由此也衍生出一個結論：倘若凡事你不知道壞東西壞經驗的名字。。。你不是就感覺到幸福了麽？不就會心安理得了麽？
舉一反三。。。
-逸寬
光靠依賴醫生和依賴藥物是解決不了病的問題的。
奈何！
-逸寬
也祝逸寬兄快樂幸福！～